Cited by 739Advanced Causal Inference TechniquesStatistical Methods in EpidemiologyStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Open access

Lund, Jennifer L., Richardson, David B., Stürmer, Til·2015·Current Epidemiology Reports

DOI 10.1007/s40471-015-0053-5PMC PMC4778958

Open this paper in CoChat — free account Open PDF

Abstract

Better understanding of biases related to selective prescribing of, and adherence to, preventive treatments has led to improvements in the design and analysis of pharmacoepidemiologic studies. One influential development has been the "active comparator, new user" study design, which seeks to emulate the design of a head-to-head randomized controlled trial. In this review, we first discuss biases that may affect pharmacoepidemiologic studies and describe their direction and magnitude in a variety of settings. We then present the historical foundations of the active comparator, new user study design and explain how this design conceptually mitigates biases leading to a paradigm shift in pharmacoepidemiology. We offer practical guidance on the implementation of the study design using administrative databases. Finally, we provide an empirical example in which the active comparator, new user study design addresses biases that have previously impeded pharmacoepidemiologic studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40471-015-0053-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796
Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
Research Methods in Occupational Epidemiology
Checkoway, H., Pearce, N. E., & Kriebel, D. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195092424.001.0001 · Cited by 889
Standardized Mortality Ratios and the "Healthy Worker Effect": Scratching Beneath the Surface
McMichael, A. J. (1976) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197603000-00009 · Cited by 770
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 647
The Evolving Concept of the Healthy Worker Survivor Effect
Arrighi, H. M., & Hertz‐Picciotto, I. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00009 · Cited by 553
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M., & Weiss, N. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi274 · Cited by 490
Confounding Control in Healthcare Database Research
Brookhart, M. A., Stürmer‎, T., Glynn, R. J., Rassen, J. A., & Schneeweiß, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181dbebe3 · Cited by 391
Self-citation

Show all 42 references

Sorted by citations

Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries
Laugesen, K., Ludvigsson, J. F., Schmidt, M., Gissler, M., Valdimarsdóttir, U. A., Lunde, A., & Sørensen, H. T. (2021) · Clinical Epidemiology · doi:10.2147/clep.s314959 · Cited by 546
Precision Medicine
Kosorok, M. R., & Laber, E. B. (2019) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-030718-105251 · Cited by 400
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
Ueda, P., Svanström, H., Melbye, M., Eliasson, B., Svensson, A., Franzén, S., Guðbjörnsdóttir, S., Hveem, K., Jonasson, C., & Pasternak, B. (2018) · BMJ · doi:10.1136/bmj.k4365 · Cited by 380
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Collaborative, T. O., Schultze, A., Walker, A. J., MacKenna, B., Morton, C. E., Bhaskaran, K., Brown, J. P., Rentsch, C. T., Williamson, E., Drysdale, H., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30415-x · Cited by 279
A Framework for Descriptive Epidemiology
Lesko, C. R., Fox, M. P., & Edwards, J. K. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac115 · Cited by 261
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators
Sendor, R., & Stürmer, T. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5407 · Cited by 233
Self-citation
Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Fu, E. L. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000152 · Cited by 207
Time‐related biases in pharmacoepidemiology
Suissa, S., & Dell’Aniello, S. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5083 · Cited by 190
Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study
Kim, D., Yang, P., You, S. C., Sung, J., Jang, E., Yu, H. T., Kim, T., Pak, H., Lee, M., Lip, G. Y. H., et al. (2021) · BMJ · doi:10.1136/bmj.n991 · Cited by 175
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Khosrow‐Khavar, F., Kim, S. C., Lee, H., Lee, S. B., & Desai, R. J. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221915 · Cited by 174
Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
Prada-Ramallal, G., Takkouche, B., & Figueiras, A. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0695-y · Cited by 161
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Kanwal, F., Kramer, J. R., Li, L., Yang, Y., Cao, Y., Yu, X., Samuel, R. E., Ali, B., Desiderio, R., Cholankeril, G. T., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4661 · Cited by 170
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer
Khosrow‐Khavar, F., Filion, K. B., Bouganim, N., Suissa, S., & Azoulay, L. (2020) · Circulation · doi:10.1161/circulationaha.119.044750 · Cited by 156
The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies
Muhlack, D. C., Hoppe, L. K., Weberpals, J. G., Brenner, H., & Schöttker, B. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.11.025 · Cited by 159
Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study
Mansi, I. A., Chansard, M., Lingvay, I., Zhang, S., Halm, E. A., & Alvarez, C. A. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5714 · Cited by 144
Association of sodium-glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study.
Wu, C.-Y., Iskander, C., Wang, C., Xiong, L. Y., Shah, B. R., Edwards, J. D., Kapral, M. K., Herrmann, N., Lanctôt, K. L., Masellis, M., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1705 · Cited by 139
Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review
Streeter, A., Lin, N. X., Crathorne, L., Haasova, M., Hyde, C., Melzer, D. R., & Henley, W. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.04.022 · Cited by 139
Glucagon‐like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
Pasternak, B., Wintzell, V., Hviid, A., Eliasson, B., Gudbjörnsdottir, S., Jonasson, C., Hveem, K., Svanström, H., Melbye, M., & Ueda, P. (2024) · BMJ · doi:10.1136/bmj-2023-078225 · Cited by 125
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Filion, K. B., Lix, L. M., Yu, O. H., Dell’Aniello, S., Douros, A., Shah, B. R., St-Jean, A., Fisher, A., Tremblay, É., Bugden, S., et al. (2020) · BMJ · doi:10.1136/bmj.m3342 · Cited by 116
Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
O’Brien, M. J., Karam, S., Wallia, A., Kang, R. H., Cooper, A., Lancki, N., Moran, M. R., Liss, D. T., Prospect, T. A., & Ackermann, R. T. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6125 · Cited by 116
Data extraction for epidemiological research (DExtER): a novel tool for automated clinical epidemiology studies
Gokhale, K. M., Chandan, J. S., Toulis, K. A., Gkoutos, G. V., Peter Tiňo, B., & Nirantharakumar, K. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00677-6 · Cited by 111
Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures
Butler, A. M., Brown, D. S., Durkin, M. J., Sahrmann, J. M., Nickel, K. B., O’Neil, C. A., Olsen, M. A. A., Hyun, D. Y., Zetts, R. M., & Newland, J. G. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.14153 · Cited by 119
Early versus later treatment start in multiple sclerosis: a register‐based cohort study
Chalmer, T. A., Baggesen, L. M., Nørgaard, M., Koch‐Henriksen, N., Magyari, M., Sørensen, P. S., & the Danish Multiple Sclerosis Group (2018) · European Journal of Neurology · doi:10.1111/ene.13692 · Cited by 110
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials
Hansford, H. J., Cashin, A. G., Jones, M. D., Swanson, S. A., Islam, N., Douglas, S. R. G., Rizzo, R. R. N., Devonshire, J. J., Williams, S. A., Dahabreh, I. J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.36023 · Cited by 116
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
Salinas, C. A., Louder, A. M., Polinski, J. M., Zhang, T. C., Bower, H., Phillips, S., Song, Y., Rashidi, E., Bosan, R., Chang, H., et al. (2022) · Rheumatology and Therapy · doi:10.1007/s40744-022-00505-1 · Cited by 102
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak, B., Wintzell, V., Melbye, M., Eliasson, B., Svensson, A., Franzén, S., Guðbjörnsdóttir, S., Hveem, K., Jonasson, C., Svanström, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1186 · Cited by 102
Considerations for Pharmacoepidemiological Studies of Drug–Cancer Associations
Pottegård, A., Friis, S., Stürmer, T., Hallas, J., & Bahmanyar, S. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12946 · Cited by 106
Self-citation
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4369 · Cited by 103
Methodological considerations when analysing and interpreting real-world data
Stürmer‎, T., Wang, T., Golightly, Y. M., Keil, A. P., Lund, J. L., & Funk, M. J. (2019) · Rheumatology · doi:10.1093/rheumatology/kez320 · Cited by 107
Self-citation
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Pasternak, B., Ueda, P., Eliasson, B., Svensson, A., Franzén, S., Guðbjörnsdóttir, S., Hveem, K., Jonasson, C., Wintzell, V., Melbye, M., et al. (2019) · BMJ · doi:10.1136/bmj.l4772 · Cited by 100
Using propensity scores to estimate effects of treatment initiation decisions: State of the science
Webster‐Clark, M., Stürmer‎, T., Wang, T., Man, K. K. C., Marinac‐Dabic, D., Rothman, K. J., Ellis, A. R., Gokhale, M., Lunt, M., Girman, C. J., et al. (2020) · Statistics in Medicine · doi:10.1002/sim.8866 · Cited by 101
Self-citation
GLP-1 based therapies and disease course of inflammatory bowel disease
Villumsen, M., Schelde, A. B., Jimenez-Solem, E., Jess, T., & Allin, K. H. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.100979 · Cited by 97
Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study
Blotière, P., Miranda, S., Weill, A., Mikaeloff, Y., Peyre, H., Ramus, F., Zureik, M., Coste, J., & Dray‐Spira, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034829 · Cited by 94
Metformin and Cancer: Solutions to a Real-World Evidence Failure
Yu, O. H. Y., & Suissa, S. (2023) · Diabetes Care · doi:10.2337/dci22-0047 · Cited by 92
Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study
Han, S. J., Ha, K. H., Lee, N., & Kim, D. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14261 · Cited by 90
Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study
Khosrow‐Khavar, F., Desai, R. J., Lee, H., Lee, S. B., & Kim, S. C. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42250 · Cited by 86
Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
Azoulay, L. (2022) · The Oncologist · doi:10.1093/oncolo/oyac114 · Cited by 79
The Expanding Role of Real-World Evidence Trials in Health Care Decision Making
Klonoff, D. C. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819832653 · Cited by 80
Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection
Dong, Y., Chang, C., Wang, J., Wu, L., Lin, J., & Toh, S. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4192 · Cited by 77
Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research
Yang, J. Y., Webster‐Clark, M., Lund, J. L., Sandler, R. S., Dellon, E. S., & Stürmer‎, T. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.04.236 · Cited by 77
Self-citation
Real-world evidence: the devil is in the detail
Gokhale, M., Stürmer‎, T., & Buse, J. B. (2020) · Diabetologia · doi:10.1007/s00125-020-05217-1 · Cited by 76
Self-citation
Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke
Ribe, A. R., Vestergaard, C. H., Vestergaard, M., Pedersen, H. S., Prior, A., Lietzen, L. W., Brynningsen, P. K., & Fenger‐Grøn, M. (2020) · Stroke · doi:10.1161/strokeaha.119.027301 · Cited by 71
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study
Lu, C.-H., Yang, C., Li, C., Hsieh, C., & Ou, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4499-5 · Cited by 70
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis
Assimon, M. M., Brookhart, M. A., & Flythe, J. E. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018101032 · Cited by 69
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
Pasternak, B., Wintzell, V., Eliasson, B., Svensson, A., Franzén, S., Guðbjörnsdóttir, S., Hveem, K., Jonasson, C., Melbye, M., Svanström, H., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2088 · Cited by 70
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
Fu, E. L., van Diepen, M., Xu, Y., Trevisan, M., Dekker, F. W., Zoccali, C., Jager, K. J., & Carrero, J. J. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa242 · Cited by 69
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Busby, J., Mills, K., Zhang, S., Liberante, F. G., & Cardwell, C. R. (2018) · Breast Cancer Research · doi:10.1186/s13058-017-0928-0 · Cited by 68
Prenatal Tdap immunization and risk of maternal and newborn adverse events.
Layton, J. B., Butler, A. M., Li, D., Boggess, K. A., Weber, D. J., McGrath, L. J., & Becker-Dreps, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.071 · Cited by 60
Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes
Landi, S. N., Radke, S., Engel, S. M., Boggess, K., Stürmer‎, T., Howe, A. S., & Funk, M. J. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.4214 · Cited by 67
Self-citation
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database
Vegas, L. P., Penso, L., Claudepierre, P., & Sbidian, É. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0364 · Cited by 67
Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
Bea, S., Son, H., Bae, J. H., Cho, S. W., Shin, J., & Cho, Y. M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15292 · Cited by 64
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
Vegas, L. P., Corvoisier, P. L., Penso, L., Paul, M., Sbidian, É., & Claudepierre, P. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab522 · Cited by 64
Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review
Wang, K., Bell, J. S., Chen, E. Y. H., Gilmartin‐Thomas, J., & Ilomäki, J. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0537-3 · Cited by 63
The importance and implications of comparator selection in pharmacoepidemiologic research
D’Arcy, M. E., Stürmer‎, T., & Lund, J. L. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0155-y · Cited by 62
Self-citation
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Alkabbani, W., Suissa, K., Gu, K. D., Cromer, S. J., Paik, J. M., Bykov, K., Hobai, I., Thompson, C. C., Wexler, D. J., & Patorno, E. (2024) · BMJ · doi:10.1136/bmj-2024-080340 · Cited by 60
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
Pradhan, R., Yin, H., Yu, O. H. Y., & Azoulay, L. (2022) · Diabetes Care · doi:10.2337/dc21-1953 · Cited by 60
Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study
Adimadhyam, S., Lee, T. A., Calip, G. S., Marsh, D. E. S., Layden, B. T., & Schumock, G. T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13459 · Cited by 55
Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan
Su, Y., Hung, J., Chang, K., Sun, C., Huang, Y.-H., Lee, C., Hung, M., Lai, C., Shao, S., & Lai, E. C. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.32584 · Cited by 55
Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding
Lund, J. L., Horváth–Puhó, E., Szépligeti, S. K., Sørensen, H. T., Pedersen, L. H., Ehrenstein, V., & Stürmer‎, T. (2017) · Clinical Epidemiology · doi:10.2147/clep.s147175 · Cited by 56
Self-citation
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
Pham, P., Schmidt, S., Lesko, L. J., Lip, G. Y. H., & Brown, J. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3593 · Cited by 55
Effects of Intermittent Energy Restriction Combined with a Mediterranean Diet on Reducing Visceral Adiposity: A Randomized Active Comparator Pilot Study
Panizza, C. E., Lim, U., Yonemori, K., Cassel, K., Wilkens, L. R., Harvie, M., Maskarinec, G., Delp, E. J., Lampe, J. W., Shepherd, J., et al. (2019) · Nutrients · doi:10.3390/nu11061386 · Cited by 56
Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
Curtis, J. R., Arora, T., Liu, Y., Lin, T., Spangler, L., Brunetti, V. C., Stad, R. K., McDermott, M., Bradbury, B. D., & Kim, M. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae079 · Cited by 54
De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival
Madden, J. M., Murphy, L., Zgaga, L., & Bennett, K. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4896-6 · Cited by 54
Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
de Gage, S. B., Collin, C., Tri, T. L., Pariente, A., Bégaud, B., Verdoux, H., Dray‐Spira, R., & Zureik, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0537-1 · Cited by 53
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs
Rahman, T., Sahrmann, J. M., Olsen, M. A. A., Nickel, K. B., Miller, J. P., Ma, C. X., & Grucza, R. A. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001513 · Cited by 53
Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study
Wetmore, J. B., Weinhandl, E. D., Yan, H., Reyes, J. L., Herzog, C. A., & Roetker, N. S. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.03.007 · Cited by 52
Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults
Wang, T., Hong, J., Gower, E. W., Pate, V., Garg, S., Buse, J. B., & Stürmer‎, T. (2018) · Diabetes Care · doi:10.2337/dc17-2285 · Cited by 54
Self-citation
Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems – a critical review and recommendations for future research
Sujan, A. C., Öberg, A. S., Quinn, P. D., & D'Onofrio, B. M. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13004 · Cited by 55
Putting GLP-1 RAs and Thyroid Cancer in Context: Additional Evidence and Remaining Doubts
Thompson, C. A., & Stürmer, T. (2023) · Diabetes Care · doi:10.2337/dci22-0052 · Cited by 51
Self-citation
Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications
Rompay, M. I. V., Solomon, K. R., Nickel, J. C., Ranganathan, G., Kantoff, P. W., & McKinlay, J. B. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.033 · Cited by 53
Considerations on the use of different comparators in pharmacovigilance: A methodological review
Gravel, C. A., & Douros, A. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15802 · Cited by 49
Methodologic Issues when Estimating Risks in Pharmacoepidemiology
Edwards, J. K., Hester, L., Gokhale, M., & Lesko, C. R. (2016) · Current Epidemiology Reports · doi:10.1007/s40471-016-0089-1 · Cited by 49
Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis
Moon, A. M., Jiang, Y., Rogal, S. S., Tapper, E. B., Lieber, S. R., & Barritt, A. S. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15639 · Cited by 49
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Shapiro, S. B., Yin, H., Yu, O. H. Y., Rej, S., Suissa, S., & Azoulay, L. (2025) · BMJ · doi:10.1136/bmj-2024-080679 · Cited by 49
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study
Larsen, T. B., Skjøth, F., Kjældgaard, J. N., Lip, G. Y. H., Nielsen, P. B., & Søgaard, M. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30054-6 · Cited by 47
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice
Krüger, N., Schneeweiss, S., Desai, R. J., Sreedhara, S. K., Kehoe, A. R., Fuse, K., Hahn, G., Schunkert, H., & Wang, S. V. (2026) · Nature Medicine · doi:10.1038/s41591-025-04102-x · Cited by 48
Immortal Time Bias in Epidemiology
Platt, R. W., Hutcheon, J. A., & Suissa, S. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-0180-5 · Cited by 48
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults
Kochar, B. D., Pate, V., Kappelman, M. D., Long, M. D., Ananthakrishnan, A. N., Chan, A. T., & Sandler, R. S. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.08.047 · Cited by 48
Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: A population-based study
Sujan, A. C., Quinn, P. D., Rickert, M. E., Wiggs, K. K., Lichtenstein, P., Larsson, H., Almqvist, C., Öberg, A. S., & D'Onofrio, B. M. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002980 · Cited by 47
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
Wetmore, J. B., Herzog, C. A., Yan, H., Reyes, J. L., Weinhandl, E. D., & Roetker, N. S. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14021021 · Cited by 49
Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment
Levenson, M. S., He, W., Chen, J., Fang, Y., Faries, D. E., Goldstein, B. A., Ho, M., Lee, K., Mishra-Kalyani, P. S., Rockhold, F. W., et al. (2021) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2021.1883473 · Cited by 46
α1-Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer’s Disease
Perez, D. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044188 · Cited by 45
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Lin, T., Kang, E. Y., Shao, S., Lai, E. C., Garg, S. J., Chen, K., Kang, J., Wu, W.-C., Lai, C., & Hwang, Y. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0221 · Cited by 48
Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis
Weberpals, J. G., Jansen, L., van Herk‐Sukel, M. P. P., Kuiper, J. G., Aarts, M. J., Vissers, P. A. J., & Brenner, H. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0304-5 · Cited by 45
Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease
Sheu, J., Tsai, M., Erickson, S. R., & Wu, C. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2305 · Cited by 46
Comparative Effectiveness Research Using Observational Data: Active Comparators to Emulate Target Trials with Inactive Comparators
Huitfeldt, A., Hernán, M. Á., Kalager, M., & Robins, J. M. (2016) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1234 · Cited by 44
Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis
Lui, D. T. W., Au, I. C. H., Tang, E. H. M., Cheung, C., Lee, C., Woo, Y. C., Wu, T., Tan, K. C. B., & Wong, C. K. H. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101510 · Cited by 44
Statins and Risk of Intracerebral Haemorrhage in a Stroke-Free Population: A Nationwide Danish Propensity Score Matched Cohort Study
Ribe, A. R., Vestergaard, C. H., Vestergaard, M., Fenger‐Grøn, M., Pedersen, H. S., Lietzen, L. W., & Brynningsen, P. K. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.02.007 · Cited by 43
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use
Lyu, H., Zhao, S. S., Yoshida, K., Tedeschi, S. K., Xu, C. Q., Nigwekar, S. U., Leder, B. Z., & Solomon, D. H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00924 · Cited by 43
Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay
Verdoodt, F., Dehlendorff, C., Jäättelä, M., Strauss, R., Pottegård, A., Hallas, J., Friis, S., & Kjær, S. K. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz217 · Cited by 43
Considerations for pharmacoepidemiological analyses in the SARS‐CoV ‐2 pandemic
Pottegård, A., Kurz, X., Moore, N. D., Christiansen, C. F., & Klungel, O. H. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5029 · Cited by 42
Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease
Jeong, S., Cho, H., Kim, Y. J., Ma, H., & Jang, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247354 · Cited by 43
Prevalence of Avoidable and Bias‐Inflicting Methodological Pitfalls in Real‐World Studies of Medication Safety and Effectiveness
Bykov, K., Patorno, E., D’Andrea, E., He, M., Lee, H., Graff, J. S., & Franklin, J. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2364 · Cited by 42
Lower risks of cirrhosis and hepatocellular carcinoma with GLP‐1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework
Yang, C., Yao, W., Yang, C., Peng, Z., Ou, H., & Kuo, S. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13751 · Cited by 45
Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population‐Based Cohort Study
Tang, H., Lu, Y., Okun, M. S., Donahoo, W. T., Ramirez‐Zamora, A., Wang, F., Huang, Y., Armstrong, M. J., Svensson, M., Virnig, B. A., et al. (2024) · Movement Disorders · doi:10.1002/mds.29992 · Cited by 44
Starting right: aligning eligibility and treatment assignment at time zero when emulating a target trial
Fu, E. L., Harhay, M. O., Schneeweiss, S., Desai, R. J., & Hernán, M. A. (2026) · BMJ · doi:10.1136/bmj-2025-084909 · Cited by 42
Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort
Lash, T. L., Riis, A. H., Ostenfeld, E. B., Erichsen, R., Vyberg, M., Ahern, T. P., & Thorlacius‐Ussing, O. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww245 · Cited by 42
Risk of diabetic macular oedema with sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes patients: A multi‐institutional cohort study in Taiwan
Su, Y., Shao, S., Lai, E. C., Lee, C., Hung, M., Lai, C., Hsu, S., & Hung, J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14445 · Cited by 42
Risk of intracranial hemorrhage associated with the use of antidepressants inhibiting serotonin reuptake: a systematic review
Douros, A., Ades, M., & Renoux, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0507-7 · Cited by 42
Angiotensin receptor blocker use and gastro‐oesophageal cancer survival: a population‐based cohort study
Busby, J., McMenamin, Ú. C., Spence, A. D., Johnston, B. T., Hughes, C., & Cardwell, C. R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14388 · Cited by 41

Authors: Lund, J. L., Richardson, D. B., & Stürmer, T.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Lund, Jennifer L.
ORCID: Lund, Jennifer L.
Richardson, David B.
Venue: Current Epidemiology Reports
Publisher: Springer Science and Business Media LLC
Published: 2015-09-30
Volume: 2
Issue: 4
Pages: 221-228
ISSN: 2196-2995 (ISSN-L)
DOI: 10.1007/s40471-015-0053-5
PMC: PMC4778958
OpenAlex: W1849521086
Cited by: 739
References: 42
Citations by year: 2026: 103 · 2025: 125 · 2024: 94 · 2023: 79 · 2022: 98 · 2021: 72 · 2020: 61 · 2019: 44 · 2018: 34 · 2017: 19 · 2016: 10
FWCI: 18.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Current Epidemiology Reports (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (2k12ca120780-16)
National Institute on Aging (R01AG023178)
National Cancer Institute (K12-CA120780)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK124723)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: bias in observational studies, head-to-head comparison, administrative databases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks